Cyclophosphamide
SSc-Systemic Sclerosis
The Children's Hospital of Zhejiang University School of MedicineSmall moleculePhase 2/3Active
BBB
72/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 60/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the SSc-Systemic Sclerosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Fludarabine The Children's Hospital of Zhejiang University School of Medicine | Early Phase 1 | C |
RD06-05 CART Cell The Children's Hospital of Zhejiang University School of Medicine | Early Phase 1 | C |
Same molecule, other indications
Cyclophosphamide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →